|
VCP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.820300E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.69019999999898E-05 |
| Normal-vs-Stage2 |
3.452100E-02 |
| Normal-vs-Stage3 |
1.881970E-01 |
| Normal-vs-Stage4 |
1.523550E-03 |
| Stage1-vs-Stage2 |
9.642400E-01 |
| Stage1-vs-Stage3 |
1.752830E-01 |
| Stage1-vs-Stage4 |
5.191600E-01 |
| Stage2-vs-Stage3 |
3.292200E-01 |
| Stage2-vs-Stage4 |
5.448800E-01 |
| Stage3-vs-Stage4 |
1.347770E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.635300E-04 |
| Normal-vs-AfricanAmerican |
3.756000E-03 |
| Normal-vs-Asian |
3.196200E-01 |
| Caucasian-vs-AfricanAmerican |
9.265800E-01 |
| Caucasian-vs-Asian |
9.705600E-01 |
| AfricanAmerican-vs-Asian |
9.960000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.83969999999878E-05 |
| Normal-vs-Female |
1.857780E-01 |
| Male-vs-Female |
1.732050E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.371550E-02 |
| Normal-vs-Extreme_Weight |
1.5635799999969E-05 |
| Normal-vs-Obese |
2.797700E-02 |
| Normal-vs-Extreme_Obese |
4.026100E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.845000E-01 |
| Normal_Weight-vs-Obese |
5.868800E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.507600E-01 |
| Extreme_Weight-vs-Obese |
6.109900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.996000E-01 |
| Obese-vs-Extreme_Obese |
2.601200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.111190E-01 |
| Normal-vs-Age(41-60Yrs) |
1.129910E-02 |
| Normal-vs-Age(61-80Yrs) |
1.550580E-04 |
| Normal-vs-Age(81-100Yrs) |
1.877960E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.047800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.616410E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.268000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.601400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.492200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.269800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.571700E-04 |
| Normal-VS-Type2 PRCC |
6.604800E-03 |
| Normal-VS-KIRP CIMP |
3.134400E-01 |
| Normal-VS-Unclassified PRCC |
1.735020E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.648400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.055400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.185800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.073800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.580200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.067200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.382300E-03 |
| Normal-vs-N1 |
2.822600E-01 |
| Normal-vs-N2 |
2.216200E-02 |
| N0-vs-N1 |
3.947800E-01 |
| N0-vs-N2 |
7.628600E-01 |
| N1-vs-N2 |
1.706360E-01 |
|
|
